Iguchi T, Ostrander P L, Mills K T, Bern H A
Cancer Res. 1985 Nov;45(11 Pt 2):5688-93.
Adenosis occurred in transplanted C57BL and BALB/c mice Müllerian-derived reproductive tract regions, cervix, and/or fornix (FX), and middle vagina but never in the urogenital sinus-derived portion of the vagina, after a 1-mo exposure to endogenous ovarian hormones or exogenous estradiol (E2). Grafts in ovariectomized hosts did not exhibit adenosis, confirming its dependence on estrogen. C57BL FX and midvaginal transplants from 1-, 3-, and 5-day-old donors but not from 7- or 10-day-old donors developed adenosis, indicating a critical period before day 6. Prolonged E2 exposure (to 2 mo) decreased the adenosis incidence observed in the C57BL FX group but not in midvaginal transplants. Progesterone added during the second half of transplantation to continuing exogenous E2 prevented this reduction in the FX group; however, adenosis incidence in the similarly treated middle vagina group was less than that observed after 1 or 2 mo of E2 treatment alone. Progesterone present throughout the 2-mo transplantation period did not significantly affect adenosis incidence induced by 2-mo exposure of midvaginal or FX grafts to E2 alone. Changes suggestive of squamous cell carcinoma were found in a few BALB/c midvaginal grafts after E2 exposure for 1 mo and in some C57BL midvaginal and FX grafts after E2 and progesterone exposure for 2 mo.
在移植的C57BL和BALB/c小鼠中,经1个月内源性卵巢激素或外源性雌二醇(E2)暴露后,苗勒管来源的生殖道区域、子宫颈和/或穹窿(FX)以及阴道中段出现腺病,但阴道泌尿生殖窦来源的部分从未出现腺病。卵巢切除宿主中的移植物未表现出腺病,证实了其对雌激素的依赖性。来自1日龄、3日龄和5日龄供体而非7日龄或10日龄供体的C57BL FX和阴道中段移植物发生了腺病,表明关键时期在第6天之前。延长E2暴露时间(至2个月)降低了C57BL FX组中观察到的腺病发生率,但阴道中段移植物中未降低。在移植后半期添加孕酮至持续的外源性E2可防止FX组出现这种降低;然而,同样处理的阴道中段组中的腺病发生率低于仅接受1或2个月E2治疗后观察到的发生率。在整个2个月的移植期内存在孕酮对仅将阴道中段或FX移植物暴露于E2 2个月诱导的腺病发生率没有显著影响。在暴露于E2 1个月后的一些BALB/c阴道中段移植物以及暴露于E2和孕酮2个月后的一些C57BL阴道中段和FX移植物中发现了提示鳞状细胞癌的变化。